Please login to the form below

Not currently logged in
Email:
Password:

treatment

This page shows the latest treatment news and features for those working in and with pharma, biotech and healthcare.

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

The Keytruda plus Lenvima was previously approved under the FDA’s accelerated approval process for the treatment of certain endometrial cancer patients. ... The combination treatment also met key secondary endpoints of overall survival (OS) and

Latest news

More from news
Approximately 9 fully matching, plus 5,454 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 3 fully matching, plus 743 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 225 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 27 fully matching, plus 582 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....